No Data
Positive Phase 2 Trial Results Drive Viking Therapeutics (VKTX) Stock Upwards
Trump Nominates Marty Makary For FDA Commissioner
Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
How Is The Market Feeling About Viking Therapeutics?
Viking Therapeutics Analyst Ratings
B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109
HugoV : Yes on our way to 90
Hanh Tran384 OP HugoV : Can’t wait!!!